The value of MRI in quantification of parametrial invasion and association with prognosis in locally advanced cervical cancer: the "PLACE" study.
Disease-free survival
Magnetic resonance imaging
Survival
Uterine cervical neoplasms
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
20 Nov 2023
20 Nov 2023
Historique:
received:
10
07
2023
accepted:
14
10
2023
revised:
21
09
2023
pubmed:
20
11
2023
medline:
20
11
2023
entrez:
19
11
2023
Statut:
aheadofprint
Résumé
This retrospective observational study aims to evaluate the association between the extent of parametrial invasion (PMI) and disease-free survival (DFS) and cancer-specific survival (CSS) in patients with locally advanced cervical cancer (LACC). This study included patients with LACC showing parametrial invasion at Magnetic Resonance Imaging (MRI). They were treated with neoadjuvant chemo-radiotherapy (CT/RT) before undergoing radical hysterectomy. The staging MRIs were reviewed retrospectively. Measurements of maximum PMI (PMI Out of 221 patients, 126 (57%) had non-metastatic lymph nodes (N-), while 95 (43%) had metastatic lymph nodes (N+). The median observation period for all these patients was 73 months (95% confidence interval [CI]: 66-77). The 5-year DFS and CSS probability rates were 75% and 85.7%, respectively, for the N- group and 54.3% and 73.6%, respectively, for the N+ group. A higher PMI The degree of PMI evaluated on MRI affects outcome in N- patients with LACC. The degree of MRI parametrial invasion affects disease-free survival and cancer-specific survival in patients with the International Federation of Gynecology and Obstetrics (FIGO) stage IIB cervical cancer. This MRI finding can be easily incorporated into routine clinical practice. • Visual assessment of parametrial invasion on MRI was not significantly associated with prognosis in locally advanced cervical cancer (LACC). • A greater degree of parametrial invasion is associated with poorer disease-free survival and cancer-specific survival in patients with LACC without metastatic lymph node involvement. • The degree of parametrial invasion at MRI has no correlation with prognosis in LACC with metastatic lymph nodes.
Identifiants
pubmed: 37981591
doi: 10.1007/s00330-023-10443-3
pii: 10.1007/s00330-023-10443-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023. The Author(s), under exclusive licence to European Society of Radiology.
Références
Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209–249
doi: 10.3322/caac.21660
pubmed: 33538338
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R (2018) Cancer of the cervix uteri. Int J Gynaecol Obstet 143(Suppl 2):22–36
doi: 10.1002/ijgo.12611
pubmed: 30306584
Chemoradiotherapy for Cervical Cancer Meta-analysis C (2010) Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst Rev CD008285
Shrivastava S, Mahantshetty U, Engineer R et al (2018) Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial. JAMA Oncol 4:506–513
doi: 10.1001/jamaoncol.2017.5179
pubmed: 29423520
pmcid: 5885185
Ferrandina G, Ercoli A, Fagotti A et al (2014) Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications. Ann Surg Oncol 21:1692–9
doi: 10.1245/s10434-013-3471-y
pubmed: 24407316
Ferrandina G, Gambacorta A, Gallotta V et al (2014) Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study. Int J Radiat Oncol Biol Phys 90:778–85
doi: 10.1016/j.ijrobp.2014.07.033
pubmed: 25585781
Pervin S, Ruma FI, Rahman K et al (2019) Adjuvant hysterectomy in patients with residual disease after radiation for locally advanced cervical cancer: a prospective longitudinal study. J Glob Oncol 5:1–7
pubmed: 30707665
Yoshida K, Kajiyama H, Yoshihara M et al (2020) The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer. Int J Clin Oncol 25:384–390
doi: 10.1007/s10147-019-01551-6
pubmed: 31552530
Shim SH, Kim SN, Chae SH, Kim JE, Lee SJ (2018) Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy: a meta-analysis. J Gynecol Oncol 29:e25
doi: 10.3802/jgo.2018.29.e25
pubmed: 29400018
pmcid: 5823986
Lu W, Lu C, Yu Z and Gao L (2021) Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: a systematic review and updated meta-analysis. Oncol Lett 21: 160
Ercoli A, Delmas V, Fanfani F et al (2005) Terminologia Anatomica versus unofficial descriptions and nomenclature of the fasciae and ligaments of the female pelvis: a dissection-based comparative study. Am J Obstet Gynecol 193:1565–73
doi: 10.1016/j.ajog.2005.05.007
pubmed: 16202758
Valentini AL, Gui B, Micco M et al (2016) MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. Diagn Interv Radiol 22:319–25
doi: 10.5152/dir.2015.15282
pubmed: 27165471
pmcid: 4956016
Manganaro L, Lakhman Y, Bharwani N et al (2021) Staging, recurrence and follow-up of uterine cervical cancer using MRI: updated guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Eur Radiol 31(10):7802–7816
Woo S, Atun R, Ward ZJ, Scott AM, Hricak H, Vargas HA (2020) Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis. Eur Radiol. 30(10):5560–5577
doi: 10.1007/s00330-020-06909-3
pubmed: 32415584
pmcid: 8353650
Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2018) Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: an updated systematic review and meta-analysis of the literature between 2012 and 2016. Eur Radiol 28:530–541
doi: 10.1007/s00330-017-4958-x
pubmed: 28726120
Matsuo K, Shimada M, Nakamura K et al (2019) Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer. Eur J Surg Oncol 45:1417–1424
doi: 10.1016/j.ejso.2019.02.019
pubmed: 30846298
pmcid: 7523386
Testa AC, Moro F, Pasciuto T et al (2018) PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery. Ultrasound Obstet Gynecol 52:110–118
doi: 10.1002/uog.18953
pubmed: 29119649
Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–47
doi: 10.1016/j.ejca.2008.10.026
pubmed: 19097774
Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C (2013) The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 266:717–40
doi: 10.1148/radiol.12120315
pubmed: 23431227
Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155–63
doi: 10.1016/j.jcm.2016.02.012
pubmed: 27330520
pmcid: 4913118
Cox D (1972) 197–220. J R Stat Soc 34:197–220
Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17:343–6
doi: 10.1016/0197-2456(96)00075-X
pubmed: 8889347
Kaplan FLMP (1958) Non parametric estimation from incomplete observations. Am J Stat Assoc 53:457–481
doi: 10.1080/01621459.1958.10501452
Di Paola V, Perillo F, Gui B et al (2022) Detection of parametrial invasion in women with uterine cervical cancer using diffusion tensor imaging at 1.5T MRI. Diagn Interv Imaging 103:472–478
doi: 10.1016/j.diii.2022.05.005
pubmed: 35641417
Park JJ, Kim CK, Park SY, Park BK (2015) Parametrial invasion in cervical cancer: fused T2-weighted imaging and high-b-value diffusion-weighted imaging with background body signal suppression at 3 T. Radiology 274:734–41
doi: 10.1148/radiol.14140920
pubmed: 25299787
Pujade-Lauraine E, Tan DSP, Leary A et al (2022) Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: a systematic and scoping review. Gynecol Oncol. 167(2):360–372
doi: 10.1016/j.ygyno.2022.08.013
pubmed: 36096973
Zhang YF, Fan Y, Zhang P, Ruan JY, Mu Y, Li JK (2022) Cervical cancer recurrence and patient survival after radical hysterectomy followed by either adjuvant chemotherapy or adjuvant radiotherapy with optional concurrent chemotherapy: a systematic review and meta-analysis. Front Oncol 12:823064
doi: 10.3389/fonc.2022.823064
pubmed: 35311123
pmcid: 8931664
ECR 2022 Book of Abstract Insights Imaging 13 (Suppl 4): 205 (2022)